Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Entertainment, Arts, and Sports Law (3)
- Intellectual Property Law (3)
- International Law (3)
- Constitutional Law (2)
- Food and Drug Law (2)
-
- Fourth Amendment (2)
- Administrative Law (1)
- Antitrust and Trade Regulation (1)
- Business (1)
- Business Organizations Law (1)
- Chemicals and Drugs (1)
- Civil Rights and Discrimination (1)
- Criminal Law (1)
- International Trade Law (1)
- Law Enforcement and Corrections (1)
- Law and Race (1)
- Medicine and Health Sciences (1)
- Pharmaceutical Preparations (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Supreme Court of the United States (1)
- Institution
Articles 1 - 13 of 13
Full-Text Articles in Entire DC Network
An Overview Of Progress In The International Regulation Of The Pharmaceutical Industry, Joan Costa-Font, Aaron Burakoff Harvard University; University Of Barcelona
An Overview Of Progress In The International Regulation Of The Pharmaceutical Industry, Joan Costa-Font, Aaron Burakoff Harvard University; University Of Barcelona
The University of New Hampshire Law Review
[Excerpt] “The pharmaceutical industry, a significant source of healthcare throughout the world, has several features that distinguish it from the rest of the health industry. In the last half-century, new technology, better technological know-how, and overall economic growth have led to widespread and rapid growth in the pharmaceutical sector. Advancements in pharmaceutical research and development have led to the production of drugs that can routinely combat afflictions that, only years ago, were untreatable or even fatal. Since 1970, the average share of Gross Domestic Product (GDP) on pharmaceutical goods has increased in most Organization for Economic Cooperation and Development (OECD) …
Road Work: Racial Profiling And Drug Interdiction On The Highway, Samuel R. Gross, Katherine Y. Barnes
Road Work: Racial Profiling And Drug Interdiction On The Highway, Samuel R. Gross, Katherine Y. Barnes
Michigan Law Review
Hypocrisy about race is hardly new in America, but the content changes. Recently the spotlight has been on racial profiling. The story of Colonel Carl Williams of the New Jersey State Police is a wellknown example. On Sunday, February 28, 1999, the Newark Star Ledger published a lengthy interview with Williams in which he talked about race and drugs: "Today . . . the drug problem is cocaine or marijuana. It is most likely a minority group that's involved with that. " Williams condemned racial profiling - "As far as racial profiling is concerned, that is absolutely not right. It …
Seeking A Balance: International Pharmaceutical Patent Protection, Public Health Crises, And The Emerging Threat Of Bio-Terrorism, Arnaldo Lacayo
Seeking A Balance: International Pharmaceutical Patent Protection, Public Health Crises, And The Emerging Threat Of Bio-Terrorism, Arnaldo Lacayo
University of Miami Inter-American Law Review
No abstract provided.
Indianapolis V. Edmond: Roadblock To Fourth Amendment Erosion Of Individual Security, Samuel Bateman
Indianapolis V. Edmond: Roadblock To Fourth Amendment Erosion Of Individual Security, Samuel Bateman
Nevada Law Journal
No abstract provided.
Key Disclosure Issues For Life Sciences Companies: Fda Product Approval, Clinical Test Results, And Government Inspections, William O. Fisher
Key Disclosure Issues For Life Sciences Companies: Fda Product Approval, Clinical Test Results, And Government Inspections, William O. Fisher
Michigan Telecommunications & Technology Law Review
The government, particularly the Food and Drug Administration ("FDA"), heavily regulates the life sciences industry. FDA actions can have an extraordinary influence on the fortunes of biotechnology companies. Timely FDA approval of a drug or medical device can permit a company to exploit an inviting market window. FDA product approval is, in turn, tied to clinical test results which demonstrate "efficacy" and safety. Delayed approval, unfavorable test results, or the denial of an FDA application may ruin a company. Beyond the FDA product approval process and related testing lie FDA inspections and the possibility that the government will investigate charges …
Regulations Governing Drugs And Performance Enhancers In Sports, Edward Jurith, Adolpho A. Birch, Robert Housman, Ronald Klempner
Regulations Governing Drugs And Performance Enhancers In Sports, Edward Jurith, Adolpho A. Birch, Robert Housman, Ronald Klempner
Fordham Intellectual Property, Media and Entertainment Law Journal
No abstract provided.
The United States’ And International Response To The Problem Of Doping In Sports, Edward H. Jurith, Bill Koenig
The United States’ And International Response To The Problem Of Doping In Sports, Edward H. Jurith, Bill Koenig
Fordham Intellectual Property, Media and Entertainment Law Journal
No abstract provided.
The Contraception Misconception: Why Prescription Contraceptives Should Be Covered By Employer Insurance Plans, Jennifer N. White
The Contraception Misconception: Why Prescription Contraceptives Should Be Covered By Employer Insurance Plans, Jennifer N. White
Hofstra Law Review
No abstract provided.
The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being Tripped By Developed Countries, Michelle M. Nerozzi
The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being Tripped By Developed Countries, Michelle M. Nerozzi
Villanova Law Review
No abstract provided.
Patenting Dilemma: Drugs For Profit Versus Drugs For Health, Christopher K. Eppich
Patenting Dilemma: Drugs For Profit Versus Drugs For Health, Christopher K. Eppich
Santa Clara Law Review
No abstract provided.
Harmonization Of Anti-Doping Code Through Arbitration: The Case Law Of The Court Of Arbitration For Sport, Frank Oschütz
Harmonization Of Anti-Doping Code Through Arbitration: The Case Law Of The Court Of Arbitration For Sport, Frank Oschütz
Marquette Sports Law Review
No abstract provided.
Rewarding Confidential Informants: Cashing In On Terrorism And Narcotics Trafficking, Douglas Kash
Rewarding Confidential Informants: Cashing In On Terrorism And Narcotics Trafficking, Douglas Kash
Case Western Reserve Journal of International Law
No abstract provided.
Access To Affordable Hiv/Aids Drugs: The Human Rights Obligations Of Multinational Pharmaceutical Corporations , Lissett Ferreira
Access To Affordable Hiv/Aids Drugs: The Human Rights Obligations Of Multinational Pharmaceutical Corporations , Lissett Ferreira
Fordham Law Review
No abstract provided.